Browsing Tag
Neurimmune
1 post
AL-S Pharma’s AP-101 prolongs survival and delays ventilator use in ALS Phase 2 trial
AL-S Pharma’s AP-101 showed survival and biomarker gains in ALS Phase 2 study. Find out what this means as the firm prepares for Phase 3.